Home › Sarcoma dei tessuti molli › Texas › Houston
Studi clinici su Sarcoma dei tessuti molli a Houston, TX
32 studi su Sarcoma dei tessuti molli cercano partecipanti presso sedi a Houston e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- UT MD Anderson Cancer Center, Houston
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
In reclutamentoFase 2
- The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
In reclutamentoFase 1/2
- MD Anderson Cancer Center, Houston
Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma
In reclutamentoFase 1/2
- UT MD Anderson Cancer Center, Houston
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
In reclutamentoFase 1/2
- Baylor College of Medicine, Houston
Anti-GD2 ADC M3554 in Advanced Solid Tumors
In reclutamentoFase 1
- The University of Texas MD Anderson Cancer Center, Houston
A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
In reclutamentoFase 1
- The University of Texas MD Anderson Cancer Center, Houston
First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma
In reclutamentoFase 1/2
- University Of Texas MD Anderson Cancer Center, Houston
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
In reclutamentoFase 1
- UT MD Anderson Cancer Center, Houston
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
In reclutamentoFase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
In reclutamentoFase 1
- UT MD Anderson Cancer Center, Houston
Actinium Therapy for Late-stage Aggressive Sarcomas
In reclutamentoFase 1
- MD Anderson Cancer Center, Houston
STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
In reclutamentoFase 1/2
- MD Anderson Cancer Center, Houston
- NEXT Houston, Houston
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
In reclutamentoStudio osservazionale
- M D Anderson Cancer Center, Houston
Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma
In reclutamentoFase 2
- MD Anderson Cancer Center, Houston
T Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy (attIL12-TIL) for Advanced/Metastatic Soft Tissue and Bone Sarcoma Patients.
In reclutamentoFase 1
- MD Anderson Cancer Center, Houston
A Study of MGC026 in Participants With Advanced Solid Tumors
In reclutamentoFase 1
- The University of Texas MD Anderson Cancer Center, Houston
- University of Texas Health Science Center at Houston, Houston
Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma
In reclutamento
- M D Anderson Cancer Center, Houston
A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab (TraPIN) in Pediatric and Young Adult Patients With Recurrent Soft Tissue Sarcomas
In reclutamentoFase 1
- The University of Texas M. D. Anderson Cancer Center, Houston
IDOV-Immune for Advanced Solid Tumors
In reclutamentoFase 1
- MD Anderson Cancer Center, Houston
Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma
In reclutamentoStudio osservazionale
- MD Anderson Cancer Center, Houston
Lead-212 PSV359 Therapy for Patients With Solid Tumors
In reclutamentoFase 1/2
- MD Anderson Cancer Center, Houston
Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors
In reclutamentoFase 2
- M D Anderson Cancer Center, Houston
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
In reclutamentoFase 1
- MD Anderson Cancer Center, Houston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
In reclutamentoFase 1/2
- MD Anderson Cancer Center, Houston
Iscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic Sarcoma
In reclutamentoFase 2
- M.D. Anderson Children's Cancer Hospital, Houston
SATURN-STS: Phase II Study of Neoadjuvant Atezolizumab With Doxorubicin, Concurrent Atezolizumab With Pre-operative Radiation Therapy and Adjuvant Atezolizumab in Patients With High-risk Surgically Resectable Extremity and Truncal Soft Tissue Sarcoma
In reclutamentoFase 2
- The University of Texas M. D. Anderson Cancer Center, Houston
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
In reclutamento
- M D Anderson Cancer Center, Houston
Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
In reclutamentoFase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma
In reclutamentoFase 1
- Texas Children's Hospital, Houston
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
In reclutamentoFase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
BostonGene and Exigent Genomic INsight Study
In reclutamentoStudio osservazionale
- Oncology Consultants, Houston
Studi su Sarcoma dei tessuti molli in altre città
- New York City, NY19 studi
- Boston, MA18 studi
- St. Louis, MO14 studi
- Columbus, OH13 studi
- Los Angeles, CA13 studi
- Washington, DC12 studi
- Memphis, TN11 studi
- Philadelphia, PA10 studi
- Rochester, MN9 studi
- Nashville, TN9 studi
- Aurora, CO9 studi
- Queens, NY9 studi
Altri studi a Houston
- Cancro del polmone non a piccole cellule145 studi
- Cancro al seno126 studi
- Cancro (tutti i tipi)121 studi
- Cancro metastatico104 studi
- Cancro colorettale102 studi
- Cancro ovarico89 studi
- Leucemia mieloide acuta85 studi
- Cancro ai polmoni78 studi
- Cancro alla prostata76 studi
- Cancro dell'endometrio68 studi
- Cancro pancreatico61 studi
- Melanoma59 studi
Fonte: ClinicalTrials.gov, dati recuperati il 3 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.